Chinese herbal medicine resources: Where we stand

被引:34
作者
Gao, Ran-ran [1 ,3 ]
Hu, Ya-ting [2 ]
Dan, Yang [1 ]
Hao, Li-jun [1 ,3 ]
Liu, Xia [2 ]
Song, Jing-yuan [1 ,3 ,4 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Plant Dev, Beijing 100193, Peoples R China
[2] Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Wuhan 430070, Peoples R China
[3] Minist Educ, Engn Res Ctr Tradit Chinese Med Resource, Beijing 100193, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Plant Dev, Yunnan Branch, Jinghong 666100, Peoples R China
基金
中国国家自然科学基金;
关键词
bioengineering; cultivation; CHM resources; germplasm resources; identification; quality analysis; PATHWAY;
D O I
10.1016/j.chmed.2019.08.004
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In recent years, the development of Chinese herbal medicine (CHM) has been challenged by shortages of CHM resources and drug safety concerns related to end products. There have been significant efforts by Chinese scholars to tackle these challenges, which are revealed by analyzing the research trend of CHM resources via surveying Chinese Traditional and Herbal Drugs (Zhong Cao Yao), a representative journal in CHM. Our study focused on 781 articles in CHM resources from 2013 to 2018 and included four subject areas: germplasm resources, quality analysis and evaluation, cultivation, and bioengineering of CHM. Discussion and prospective for future investigations were also presented, including: construct the core germplasm of medicinal plants and expand germplasms; combine molecular research with field experiments and promote the deeper study of cultivation of CHM plants; improve the quality evaluation method of CHM and strengthen the identification of Chinese patented medicines; promote the sustainable development of CHM resources by utilizing bioengineering and synthetic biology. This study helps international scholars understand the status quo of CHM research and provides theoretical support for the healthy, modern, and international development of CHM, and it will facilitate the sustainable development of the traditional Chinese medicine industry. (C) 2019 Tianjin Press of Chinese Herbal Medicines. Published by Elsevier B.V.
引用
收藏
页码:3 / 13
页数:11
相关论文
共 91 条
[1]   Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli [J].
Ajikumar, Parayil Kumaran ;
Xiao, Wen-Hai ;
Tyo, Keith E. J. ;
Wang, Yong ;
Simeon, Fritz ;
Leonard, Effendi ;
Mucha, Oliver ;
Phon, Too Heng ;
Pfeifer, Blaine ;
Stephanopoulos, Gregory .
SCIENCE, 2010, 330 (6000) :70-74
[2]  
[曹煌 Cao Huang], 2016, [中草药, Chinese Traditional and Herbal Drugs], V47, P1962
[3]  
[柴锟 Chai Kun], 2014, [中草药, Chinese Traditional and Herbal Drugs], V45, P2974
[4]  
Chen Shi-Lin, 2016, Zhongguo Zhong Yao Za Zhi, V41, P3881, DOI 10.4268/cjcmm20162101
[5]   A renaissance in herbal medicine identification: From morphology to DNA [J].
Chen, Shilin ;
Pang, Xiaohui ;
Song, Jingyuan ;
Shi, Linchun ;
Yao, Hui ;
Han, Jianping ;
Leon, Christine .
BIOTECHNOLOGY ADVANCES, 2014, 32 (07) :1237-1244
[6]   Biological ingredient analysis of traditional Chinese medicine preparation based on high-throughput sequencing: the story for Liuwei Dihuang Wan [J].
Cheng, Xinwei ;
Su, Xiaoquan ;
Chen, Xiaohua ;
Zhao, Huanxin ;
Bo, Cunpei ;
Xu, Jian ;
Bai, Hong ;
Ning, Kang .
SCIENTIFIC REPORTS, 2014, 4
[7]   Sterigmatocystin: A mycotoxin to be seriously considered [J].
Diaz Nieto, Cesar Horacio ;
Marcelo Granero, Adrian ;
Alicia Zon, Maria ;
Fernandez, Hector .
FOOD AND CHEMICAL TOXICOLOGY, 2018, 118 :460-470
[8]  
[丁铃 Ding Ling], 2016, [中草药, Chinese Traditional and Herbal Drugs], V47, P1935
[9]  
[方玲 Fang Ling], 2013, [中草药, Chinese Traditional and Herbal Drugs], V44, P229
[10]  
Frankel O. H., 1984, Genetic manipulation: impact on man and society., P161